This stock is Eron on steroids. No chance it will ever justify a tenth of its valuation one day. Everyone here knows that a correction to less than $500 is coming after ER. You won't beat the pros. The train is full of retail investors in FOMO mood buying with market orders. This will be bloody Thursday.
精彩评论